Management of Bispecifc AE’s in the Community Setting of Multiple Myeloma Patients
Panelists discuss how referral types for multiple myeloma patients vary widely, including newly diagnosed cases, relapsed/refractory disease, and specific therapy considerations like bispecifics, with processes differing between in-state and out-of-state referrals due to logistical and insurance factors.
Video content above is prompted by the following:
- What types of referrals do you usually do?
- Is the process similar/different for in-state vs out-state?
- How do social factors play into the referral process?
- How do the AEs differ based on the class of bispecific? Which AEs are you seeing in practice?
- How are they managed?
Recent Videos
Related Content
Considering NCCN Guidelines to Determine Maintenance Therapy Multiple Myeloma
February 15th 2025Article
During the 66th American Society of Hematology Annual Meeting and Exposition, experts in multiple myeloma gathered to discuss the impact of maintenance therapy and minimal residual disease (MRD) in patients with newly diagnosed transplant-eligible or -ineligible multiple myeloma.
